In Brief: FDA's Orthopedic and Rehabilitation Devices Advisory Panel
This article was originally published in The Gray Sheet
Executive SummaryFDA's Orthopedic and Rehabilitation Devices Advisory Panel: Will review premarket approval applications for U.S. Surgical's Ray Threaded Spinal Fusion Cage and Spine-Tech's BAK fusion implant at a May 23 meeting at the Holiday Inn in Gaithersburg, Maryland. The May 23 public session will follow a closed session on May 22. For more information, contact FDA's Andrew Novick, 301/594-1296...
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.